Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

In vitro assessment of clevidipine using the profilin1 hypertensive mouse model.

Hassanain HH, Hassona MD, Puente EG, Sun C, Abouelnaga ZA, Tulman DB, Bergese SD.

Pharmaceuticals (Basel). 2013 Apr 29;6(5):623-33. doi: 10.3390/ph6050623.

2.

Cardiac remodeling caused by transgenic overexpression of a corn Rac gene.

Elnakish MT, Awad MM, Hassona MD, Alhaj MA, Kulkarni A, Citro LA, Sayyid M, Abouelnaga ZA, El-Sayed O, Kuppusamy P, Moldovan L, Khan M, Hassanain HH.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H868-80. doi: 10.1152/ajpheart.00807.2010. Epub 2011 May 27.

3.

The effect of selective antihypertensive drugs on the vascular remodeling-associated hypertension: insights from a profilin1 transgenic mouse model.

Hassona MD, Elnakish MT, Abouelnaga ZA, Alhaj M, Wani AA, Hassanain H.

J Cardiovasc Pharmacol. 2011 May;57(5):550-8. doi: 10.1097/FJC.0b013e318212b1c2.

PMID:
21326111
4.

Vascular hypertrophy-associated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries.

Hassona MD, Abouelnaga ZA, Elnakish MT, Awad MM, Alhaj M, Goldschmidt-Clermont PJ, Hassanain H.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2112-20. doi: 10.1152/ajpheart.00016.2010. Epub 2010 Apr 16.

5.

Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1.

Moustafa-Bayoumi M, Alhaj MA, El-Sayed O, Wisel S, Chotani MA, Abouelnaga ZA, Hassona MD, Rigatto K, Morris M, Nuovo G, Zweier JL, Goldschmidt-Clermont P, Hassanain H.

J Biol Chem. 2007 Dec 28;282(52):37632-9. Epub 2007 Oct 16.

Supplemental Content

Loading ...
Support Center